Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds antigen or epitope whose amino acid sequence is...
Reexamination Certificate
2006-06-20
2006-06-20
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds antigen or epitope whose amino acid sequence is...
C514S009100, C514S013800, C514S014800, C514S015800, C514S016700, C514S017400, C530S317000, C530S326000, C530S327000, C530S328000, C530S329000, C530S330000, C530S387900
Reexamination Certificate
active
07063842
ABSTRACT:
Modulating agents for inhibiting an interaction between α-catenin and β-catenin are provided. The modulating agents comprise one or more of: (a) a β-catenin HAV motif; (b) a peptide analogue or mimetic of a β-catenin HAV motif; or (c) an antibody or antigen-binding fragment thereof that specifically binds to a β-catenin HAV motif. Methods for using such modulating agents for inhibiting cadherin-mediated cell adhesion in a variety of contexts are also provided.
REFERENCES:
patent: 5610281 (1997-03-01), Brenner et al.
patent: 5922855 (1999-07-01), Liskay et al.
patent: 5972884 (1999-10-01), Cohen et al.
patent: 6031072 (2000-02-01), Blaschuk et al.
patent: 6551994 (2003-04-01), Blaschuk et al.
patent: 6677116 (2004-01-01), Blaschuk et al.
patent: 6683048 (2004-01-01), Blaschuk et al.
patent: WO 91/04745 (1991-04-01), None
patent: WO 98/02452 (1998-01-01), None
patent: WO 98/42296 (1998-10-01), None
patent: WO 98/45319 (1998-10-01), None
Syu et al. Epitope characterization by modifications of antigens . . . Journal of Immunological Methods. 1989, vol. 118, pp. 153-160.
Aberle et al., “Assembly of the cadherin-catenin complex in vitro with recombinant proteins,” Journal of Cell Science 107: 3655-3663, 1994.
Blaschuk et al., “Identification of a Cadherin Cell Adhesion Recognition Sequence,” Developmental Biology 139: 227-229, 1990.
Bullions and Levine, “The role of beta-catenin in cell adhesion, signal transduciton, and cancer,” Current Opinion in Oncology 10: 81-87, 1998.
Jou et al., “Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex,” Proc. Natl. Acad. Sci. USA 92: 5067-5071, 1995.
Lutz et al., “Secondary Structure of the HAV Peptide Which Regulates Caherin-Cadherin Interaction,” Journal of Biomolecular Structure & Dynamics 13(3): 447-455, 1995.
Su et al., “Association of the APC Tumor Suppressor Protein with Catenins,” Science 262: 1734-1737, 1993.
Wheelock et al., “Membrane-Cytoskeleton Interactions with Cadherin Cell Adhesion Proteins: Roles of Catenins as Linker Proteins,” Current Topics in Membranes 43: 169-185, 1996.
Willems et al., “Cadherin-dependent cell aggregation is affected by decapeptide derived from rat extracellular super-oxide dismutase,” FEBS Letters 363: 289-292, 1995.
Blaschuk and Gour, “Compounds and Methods for Stimulating Gene Expression and Cellular Differentiation,” U.S. Appl. No. 09/265,107, filed Mar. 9, 1999.
Blaschuk, O.W. et al., “Compounds and Methods for Stimulating β-Catenin Mediated Gene Expression and Differentiation,” U.S. Appl. No. 09/545,433, filed Apr. 5, 2000.
Blaschuk, O.W. et al., “Compounds and Methods for Modulating Beta-Catenin Mediated Gene Expression,” U.S. Appl. No. 09/551,976, filed Apr. 14, 2000.
Bullions, L.C. et al., “The role of beta-catenin in cell adhesion, signal transduction, and cancer,”Current Opinion in Oncology10: 81-87, 1998.
Gat, U. et al., “De Novo Hair Follicle Morphogenesis and Hair Tumors in Mice Expressing a Truncated β-Catenin in Skin,”Cell95: 605-614, Nov. 25, 1998.
Hatta, K. et al., “Cloning and Expression of cDNA Encoding a Neural Calcium-dependent Cell Adhesion Molecule: Its Identity in the Cadherin Gene Family,”The Journal of Cell Biology106: 873-881, Mar. 1988.
Nagahara, H. et al., “Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip 1induces cell migration,”Nature Medicine4(12): 1449-1452, Dec. 1998.
Oro and Scott, “Splitting Hairs: Dissecting Roles of Signaling Systems in Epidermal Development,”Cell95: 575-578, Nov. 25, 1998.
Willert and Nusse, “β-catenin: a key mediator of Wnt singnaling,”Current Opinion in Genetics & Development8: 95-102, 1998.
Blaschuk Orest W
Gour Barbara J
McGill University
Russel Jeffrey Edwin
Seed IP Law Group PLLC
LandOfFree
Compounds and methods for inhibiting the interaction between... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for inhibiting the interaction between..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for inhibiting the interaction between... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3688583